The Valley Desk

NCT03713593 · Interventional trial

Safety and Efficacy of Lenvatinib (E7080/MK-7902) in Combination With Pembrolizumab (MK-3475) Versus Lenvatinib as First-line Therapy in Participants With Advanced Hepatocellular Carcinoma (MK-7902-002/E7080-G000-311/LEAP-002)

Overall registry status Completed

Phase 3

Conditions Carcinoma, Hepatocellular

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov